2-(Dimethylamino)pyrimidine-4-carbaldehyde → 1-cyclopentyl-6-[(3S,4S)-1-{[2-(dimethylamino)pyrimidin-4-yl]methyl}-4-methylpyrrolidin-3-yl]-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one
Reaction equation
[CH:1]1([N:6]2[C:10]3[N:11]=[C:12]([C@H:16]4[C@H:20]([CH3:21])[CH2:19][NH:18][CH2:17]4)[NH:13][C:14](=[O:15])[C:9]=3[CH:8]=[N:7]2)[CH2:5][CH2:4][CH2:3][CH2:2]1.[CH3:22][N:23]([CH3:32])[C:24]1[N:29]=[C:28]([CH:30]=O)[CH:27]=[CH:26][N:25]=1>>[CH:1]1([N:6]2[C:10]3[N:11]=[C:12]([C@H:16]4[C@H:20]([CH3:21])[CH2:19][N:18]([CH2:30][C:28]5[CH:27]=[CH:26][N:25]=[C:24]([N:23]([CH3:32])[CH3:22])[N:29]=5)[CH2:17]4)[NH:13][C:14](=[O:15])[C:9]=3[CH:8]=[N:7]2)[CH2:5][CH2:4][CH2:3][CH2:2]1Participants
3
Reactant 2
Product 1
Procedure
Following the procedure for the preparation of 1-cyclopentyl-6-[(3,4-trans)-4-methyl-1-(pyridin-3-ylmethyl)pyrrolidin-3-yl]-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one but substituting 1-cyclopentyl-6-[(3S,4S)-4-methylpyrrolidin-3-yl]-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one and 2-(dimethylamino)pyrimidine-4-carbaldehyde provided the title compound. 400 MHz 1H NMR (CDCl3) δ 8.24-8.21 (m, 1H), 8.00-7.99 (m, 1H), 6.52-6.50 (m, 1H), 5.13-5.10 (m, 1H), 3.72-3.68 (m, 1H), 3.56-3.52 (m, 1H), 3.46-3.40 (m, 3H), 3.17-3.11 (m, 7H), 2.84-2.82 (m, 1H), 2.64-2.60 (m, 1H), 2.44-2.38 (m, 1H), 2.06-1.92 (m, 5H), 1.66-1.65 (m, 2H), 1.20-1.16 (m, 3H). MS: (M+H m/z=423.1).
Sources & evidence
- ORD record
- ord-ca9b2a6d8b8948768351fcaa673412d7
- Source dataset
- uspto-grants-2011_06
- Patent number
- US07964607B2
Reaction notes
Loading…